ANEMIA OR LOW HEMOGLOBIN LEVELS PRECEDING PARKINSON DISEASE: A CASE-CONTROL STUDY
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read the article by Savica et al.1 with interest. The authors explore a possible association between preceding anemia and Parkinson disease (PD). There are 2 issues that we would like to bring to the authors' attention.
First, the strength of this association seemed to increase with time between occurrence of anemia and onset of PD. However, there were no data on current hemoglobin levels in their patients with PD. All of the hypothetical mechanisms discussed to explain this association including systemic onset of PD process; iron, folate, or other deficiency; or shared genetic variants or early life risk factors would also be compatible with anemia persisting after PD onset.
We analyzed complete blood counts from a large and well-characterized prevalence sample of patients with PD and controls (n = 209). In 83 idiopathic PD (IPD) and 91 control participants comparable for age and gender distribution, we did not observe any difference in hemoglobin levels (IPD 14.1 ± 1.4 g/dL vs controls 14.3 ± 1.2 g/dL) or in blood count or erythrocyte volume. These findings remained stable in gender-stratified analyses and the expected gender difference in hemoglobin levels was confirmed.
In addition, we followed the authors' hypothesis regarding genetic variants or early life risk factors contributing to both anemia and PD. We speculated that known PD genes might …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal gangliaF. Binkofski, K. Reetz, C. Gaser et al.Neurology, August 27, 2007 -
Articles
Frequency of LRRK2 mutations in early- and late-onset Parkinson diseaseL. N. Clark, Y. Wang, E. Karlins et al.Neurology, October 18, 2006 -
Article
Low hemoglobin and hematoma expansion after intracerebral hemorrhageDavid J. Roh, David J. Albers, Jessica Magid-Bernstein et al.Neurology, June 17, 2019 -
Articles
Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficitC. Eggers, A. Schmidt, J. Hagenah et al.Neurology, May 31, 2010